LifeBridge Innovations
LifeBridge Innovations: Pioneering advanced cancer treatments with patented ATTF therapy for improved patient life quality.
Founded
2016LifeBridge Innovations: Pioneering advanced cancer treatments with patented ATTF therapy for improved patient life quality.
LifeBridge Innovations is a life science company dedicated to improving the quality of life for patients with advanced cancer. Utilizing its patented Adaptive Tumor Treating Field (ATTF) therapy, the company aims to transform metastatic cancer from a terminal prognosis into a manageable condition. Its mission focuses on accelerating the availability of promising cancer treatments, particularly those that have shown safety and efficacy in preclinical and early-phase clinical trials.
LifeBridge Innovations has made significant strides in cancer treatment, with its ATTF therapy offering new hope for patients. The company's innovative approach has garnered attention in the medical community, contributing to a shift in how metastatic cancer is managed. By prioritizing rapid development and deployment of effective therapies, LifeBridge Innovations is making a substantial impact on patient outcomes and the broader field of oncology.
Companies similar to LifeBridge Innovations include Advanced Cancer Therapeutics, Affigen, Advanced Chemotherapy Technologies and Window Therapeutics.
LifeBridge Innovations was founded in 2016.
LifeBridge Innovations' headquarters is located in Longwood, FL, US.
LifeBridge Innovations' most recent funding round was for $45.4k (USD) in July 2022.
As of Jul 12, 2022, LifeBridge Innovations has disclosed funding of $68.5k (USD). Undisclosed round amounts are excluded.
LifeBridge Innovations has 7 employees as of Feb 4, 2024.
Window Therapeutics
windowtx.com
